Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice history

Kindred Biosciences, Inc. News

Nanox Higher on Application to FDA for Medical Imaging System

Nanox shares climbed after the medical-imaging-tech company applied to the FDA for clearance of a system that produces scans of human body parts.

5 Top Stock Gainers for Wednesday: Kindred, SoFi, Rambus

Kindred Biosciences, SoFi Technologies, Centene, Rambus and Sunrun are five top stock gainers for Wednesday.

Altimmune Higher After Phase 1 Progress With Obesity Drug

Altimmune jumped after it reported progress from its Phase 1 trial of ALT-801, a drug for obesity and liver disease.

Kindred Biosciences Jumps on $440 Million Deal to Merge With Elanco Animal Health

Elanco expects the transaction to add about $100 million to the company's innovation revenue expectations for fiscal 2025.

Premarket Movers Wednesday: Roblox, Kindred Biosciences, DraftKings

Stocks moving in premarket trading Wednesday include Roblox, Oracle, DraftKings, Kindred Biosciences and Mannkind.

Breaking News

Gap Stock Slumps On Wider Q1 Loss, Grim Profit Outlook As Shoppers Shun Casual Apparel

"Supply chain challenges and persistent delays significantly limited the brand's responsive abilities" to changing consumer trends, CEO Sonia Syngal told investors Thursday.

Big Lots Stock Crumbles After Surprise Q1 Loss As Inflation, Gas Price Surge Bites Spending

"We believe the slowdown was caused by the spending pressure our consumers felt from higher gas prices and broader inflation," said CEO Bruce Thorn.

Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.